Bivalirudin versus heparin in percutaneous coronary intervention—a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb/IIIa strategy-Reference-Cited by-同舟云学术

Bivalirudin versus heparin in percutaneous coronary intervention—a systematic review and meta-analysis of randomized trials stratified by adjunctive glycoprotein IIb/IIIa strategy

Published:2018-06 Issue:6 Volume:10 Page:3341-3360
ISSN:2072-1439
Container-title:Journal of Thoracic Disease
language:
Short-container-title:J. Thorac. Dis.

Author:

Anantha-Narayanan Mahesh,Anugula Dixitha,Gujjula Nagarjuna R.,Reddy Yogesh N. V.,Baskaran Janani,Kaushik Manu,Alla Venkata M.,Raveendran Ganesh

Publisher

AME Publishing Company

Subject

Pulmonary and Respiratory Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis;Cardiology Journal;2023-11-09

2. Bivalirudin versus unfractionated heparin in patients with myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized controlled trials;Cardiovascular Revascularization Medicine;2023-10

3. Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions;Heliyon;2023-02

4. A meta‐analysis and cost‐minimization analysis of bivalirudin versus heparin in high‐risk patients for percutaneous coronary intervention;Pharmacology Research & Perspectives;2021-05

5. Anticoagulants Used in Cardiac Catheterization of Patients With Chronic Lymphocytic Leukemia: A Case Report and Overview;Cureus;2021-03-01